TVAMP
IBB icon

Tennessee Valley Asset Management Partners’s iShares Biotechnology ETF IBB Stock Holding History

Tennessee Valley Asset Management Partners’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-323
Closed -$43.9K – 392
2023
Q4 		$43.9K Buy
+323
New +$39.4K 0.01% 245

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Tennessee Valley Asset Management Partners's IBB Position: Q1 2024 in Review

Tennessee Valley Asset Management Partners sold out of iShares Biotechnology ETF (IBB) in Q1 2024, closing a stake of 323 shares — an estimated $43.9K sold.

Tennessee Valley Asset Management Partners first reported a position in IBB in Q4 2023 and held it in 1 quarter. The position peaked at $43.9K in Q4 2023. 899 funds tracked by Wall St. Rank hold IBB as of Q1 2024.

  • Tennessee Valley Asset Management Partners reported no remaining iShares Biotechnology ETF position as of Q1 2024 after selling out during the quarter.
  • Tennessee Valley Asset Management Partners sold 323 iShares Biotechnology ETF shares in Q1 2024, an estimated $43.9K.
  • Tennessee Valley Asset Management Partners first reported a position in iShares Biotechnology ETF in Q4 2023 and held it in 1 quarter.
  • Tennessee Valley Asset Management Partners's iShares Biotechnology ETF position peaked at $43.9K in Q4 2023.
  • 899 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2024.

Based on Tennessee Valley Asset Management Partners's 13F filing for Q1 2024, filed 23 Apr 2024.